Observational Study
Copyright ©The Author(s) 2016.
World J Hepatol. Dec 28, 2016; 8(36): 1623-1628
Published online Dec 28, 2016. doi: 10.4254/wjh.v8.i36.1623
Table 1 Characteristics of those with liver disease identified as a result of study screening
Subject numberGenderAge (yr)EthnicityPrior DDI exposure (mo)Time since DDI (yr)BMI (kg/m2)MAST scoreALT (IU/mL)PLTs (106/L)PTTAlk Phos (U/L)FS (kPa)Ultrasound resultsBiopsy resultsHVPGFib 4
Participants who accepted to undergo TJLB as a result of study screening
1Male43White British81725.5807717514.08310SplenomegalyNRH with mild steatosis51.29
2Male59White British40624.4203617514.8938NormalNRH42.39
3Male48White British9629.7603218414.3108NRFatty liver, SplenomegalyModerate steatosis31.08
4Male52White British70724.6905024211.7445.6Fatty liverMild steatosis30.79
5Male49White Other34428.5416021514.08312.6Fatty liverModerate steatosis, moderate fibrosis31.38
6Male52White British211128.6715825713.443NRFatty liverModerate steatosisNot done1.02
7Male62White Other131332.5625617511.145NRFatty liverModerate steatosis22.25
8Male50White British117331.18012520410.7588.7Fatty liverMild fibrosis with mild steatosis21.71
9Female56Black African241136.9602720812.3674.4Coarse echotextureNormal Architecture51.07
10Male57White British61404019013.971NRSplenomegalyNormal Architecture31.74
11Male51White Irish103420.3005622810.81544.8Coarse echotextureNormal Architecture31.04
12Male52White Other44521.0762422411.4629.1NormalNormal Architecture21.16
Participants who refused TJLB offered as a result of study screening
13Male46White British74221.460181776010NormalDeclined1.41
14Male41White British97325.650631881017.6SplenomegalyDeclined1.30
15Male47White British33524.39034238587.1Fatty liver, dampened waveformDeclined0.99
16Male61White British110220.75135246719.2NormalDeclined1.39
17Male54White British28528.93132333584.3Fatty liverDeclined0.67